(Q34809362)

4 August 2017

1 reference

title

Use of cardiovascular medications in the elderly (English)

1 reference

4 August 2017

1 reference

Jaffar Ali Raza

1

1 reference

4 August 2017

Assad Movahed

series ordinal

2

1 reference

4 August 2017

publication date

1 October 2002

1 reference

International Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

85

1 reference

4 August 2017

issue

2-3

1 reference

4 August 2017

page(s)

203-215

1 reference

Drug use in an ambulatory elderly population: a five-year update

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Role of muscle loss in the age-associated reduction in VO2 max

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Echocardiographic assessment of a normal adult aging population

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Diminished inotropic response of aged myocardium to catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Aortic endothelial and subendothelial cells in experimental hypertension and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of age on ventricular-vascular coupling.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of age and aerobic capacity on arterial stiffness in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Improved arterial distensibility in normotensive subjects on a low salt diet

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Gender differences and aging: effects on the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Angiotensin II activates programmed myocyte cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Changes in myosin isoenzymes, ATPase activity, and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

ATPase activity and force production in myofibrils and twitch characteristics in intact muscle from neonatal, adult, and senescent rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of aging on left ventricular diastolic filling in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Cardiovascular aging in health

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Atrial kinetics and left ventricular diastolic filling in the healthy elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Cardiovascular regulatory mechanisms in advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric, and enzymatic evaluations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Transforming growth factor-beta in disease: the dark side of tissue repair

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Aging of the vascular wall and atherogenesis: role of the elastin-laminin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Plasma noradrenaline increases with age

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Cardiovascular pharmacology of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of ageing on drug absorption from the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of ageing on the hepatic clearance of propranolol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of aging on percutaneous absorption in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Altered pharmacokinetics in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of age upon the affinity of microsomal mono-oxygenase enzymes for substrate in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of age and gender on in vitro properties of human liver microsomal monooxygenases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of age on pathways of drug metabolism in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of age on mono-oxygenase enzyme kinetics in rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of age upon liver volume and apparent liver blood flow in healthy man.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Geriatric pharmacokinetics and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Changes in renal function with aging. Implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Afferent baroreflex dysfunction and age-related orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of posture on blood pressure in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Reduced β-adrenoceptor sensitivity in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Dopaminergic responses in the Fischer 344 rat heart: preserved chronotropic and dromotropic responses with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Amiodarone pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Drug interactions with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Noncardiac side-effects of long-term oral amiodarone in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The thyroid and the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Utility of Beta‐Blockade Treatment for Older Postinfarction Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Use of Digoxin, Diuretics, Beta Blockers, Angiotensin‐Converting Enzyme Inhibitors, and Calcium Channel Blockers in Older Patients in an Academic Hospital‐Based Geriatrics Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Serum concentration-effect relationship of (+/-)-nicardipine and nifedipine in elderly hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Digoxin toxicity in the aged. Characterising and avoiding the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Symposium on geriatrics--Part I: Drug prescribing for elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Bumetanide and furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Diuretics, Serum and Intracellular Electrolyte Levels, and Ventricular Arrhythmias in Hypertensive Men

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Pharmacokinetics of amiloride in renal and hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

New insights into the pharmacokinetics of spironolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The molecular-weight range of mucosal-heparin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Delayed elimination of enoxaparine in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Effect of itraconazole on the pharmacokinetics of atorvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Management and dosing of warfarin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Interactions of warfarin with drugs and food

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

Anticoagulants in older patients. A safety perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900193-6

7 January 2021

10.1016/S0167-5273(02)00193-6

Identifiers

DOI

1 reference

4 August 2017

1 reference